12
Jan
2012
Posted in I - Series C, Q - 3Q11, R - INTERNATIONAL, X - Coagulation, X - Device (Hemostat)
LifeBond (Israel) a clinical-stage medical device company focused on surgical hemostats, sealants and coagulation, closed a $20M Series C financing. Participants include Giza Venture Capital, Aurum Ventures, Johnson & Johnson Development Corp. and Pitango Venture Capital.
Thanx for your patience as we catch-up.
26
Apr
2009